Carl L Gordon
Carl L Gordon's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a link…
Insider buying and selling since 2011
Carl L Gordon bought shares on the open market in 10 different years since 2011 across 13 companies. Sales in 5 of the 16 years since 2011.
Carl L Gordon reported 38 open-market purchases and 66 sales since 2011; purchases in 10 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | 4×4 trades | 1×1 trade |
| 2024 | 6×6 trades | 3×3 trades |
| 2023 | 4×4 trades | — |
| 2022 | 7×7 trades | — |
| 2021 | 2×2 trades | 14×14 trades |
| 2020 | 3×3 trades | — |
| 2019 | 3×3 trades | — |
| 2017 | 1×1 trade | — |
| 2016 | 4×4 trades | — |
| 2012 | — | 6×6 trades |
| 2011 | 4×4 trades | 42×42 trades |
Insider at 13 companies
- Compass Therapeutics CMPX2020–2025 · 10 purchases, 1 sale
- Mbx Biosciences MBX2024–2025 · 6 purchases, 0 sales
- Adicet Bio ACET2023–2024 · 7 purchases, 0 sales
- Keros Therapeutics KROS2020–2024 · 1 purchase, 2 sales
- Arrivent Biopharma AVBP2024 · 1 purchase, 0 sales
- Tessera Defense & Homeland Security HLSQ2024 · 0 purchases, 1 sale
- Oric Pharmaceuticals ORIC2020–2021 · 1 purchase, 14 sales
- Alector ALEC2019 · 3 purchases, 0 sales
- X4 Pharmaceuticals XFOR2017 · 1 purchase, 0 sales
- Intellia Therapeutics NTLA2016 · 2 purchases, 0 sales
- Cartesian Therapeutics RNAC2016 · 2 purchases, 0 sales
- Amarin Corp Plc\Uk AMRN2011–2012 · 0 purchases, 48 sales
- Pacira BioSciences, Inc. PCRX2011 · 4 purchases, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Carl L Gordon's trades
Has Carl L Gordon bought shares on the open market?
Carl L Gordon bought shares on the open market in 10 different years since 2011 across 13 companies. Sales in 5 of the 16 years since 2011.
When did Carl L Gordon last buy or sell shares?
In SEC filings since 2011: the latest open-market purchase is from 2025; the latest open-market sale is from 2025.
Which companies has Carl L Gordon traded as an insider?
13 companies: Compass Therapeutics (CMPX, 2020–2025), Mbx Biosciences (MBX, 2024–2025), Adicet Bio (ACET, 2023–2024), Keros Therapeutics (KROS, 2020–2024), Arrivent Biopharma (AVBP, 2024) and others.